Pradient
Pradient
Extracting decades of corporate litigation exposure data from SEC filings to support investigative research into pharmaceutical and industrial industry practices.
A nationally recognized investigative journalist and New York Times bestselling author engaged Pradient to provide comprehensive litigation cost analysis across major U.S. corporations. The client's work focuses on exposing corporate practices in the pharmaceutical and industrial sectors, and required rigorous, court-ready financial documentation to support ongoing research and publication efforts.
Litigation exposure is buried deep within corporate disclosures. Each company discloses settlements, judgments, reserves, and contingent liabilities across hundreds of pages of annual 10-K filings, in inconsistent formats and language that change from year to year and company to company. Reconstructing a decade-long picture of legal exposure by hand is slow, error-prone, and difficult to defend under scrutiny.
Pradient systematically reviewed more than 60 annual 10-K filings spanning six major corporations, covering 10–11 years of disclosures per company. Litigation-related figures were extracted directly from the primary-source filings and normalized into a consistent structure, allowing year-over-year and cross-company comparison for the first time.
Each company's exposure was compiled into a standardized five-sheet workbook, separating raw disclosures, normalized figures, and summary views so the underlying numbers always trace back to the exact filing they came from. Every data point was verified against the original SEC source, producing documentation built to withstand the scrutiny of fact-checkers, editors, and legal review.
Pradient transforms unstructured regulatory and financial data into structured, actionable intelligence — with the traceability that high-stakes decisions require.
The client received a fully traceable, primary-source-verified dataset quantifying litigation exposure across six corporations over more than a decade — including a single-year peak exposure of $16.6B. The standardized workbooks turned an unstructured tangle of regulatory filings into a defensible evidentiary foundation, ready to support investigative research, publication, and fact-checking at the standard a New York Times bestselling author demands.
This engagement exemplifies Pradient's core capability: transforming unstructured regulatory and financial data into structured, actionable intelligence. Our approach combines deep domain expertise in SEC filings and corporate disclosure practices with rigorous extraction methodology and presentation standards designed for the most demanding audiences.
Whether the end use is investigative journalism, litigation support, regulatory analysis, or investment due diligence, Pradient delivers the precision and traceability that high-stakes decisions require.
Pradient turns unstructured regulatory, legal, and financial records into structured, verifiable intelligence. Let's talk about your project.
Get in Touch